Citing Us


For citing previous versions of GPRO, please use the following reference:

Futami R, Muñoz-Pomer A, Viu JM, Domínguez-Escribà L, Covelli L, Bernet GP, Sempere JM, Moya A, Llorens C.
GPRO: the professional tool for management, functional analysis and annotation of omic sequences and databases (2011).
Biotechvana Bioinformatics: 2011-SOFT3.
If you want to cite SeqEditor, RNAseq or VariantSeq tools, use the following references:

Seqeditor:

Hafez A, Futami R, Arastehfar A, Daneshnia F, Miguel A, Roig FJ, Soriano B, Perez-Sánchez J, Boekhout T, Gabaldón T, Llorens C. 2020.
SeqEditor: an application for primer design and sequence analysis with or without GTF/GFF files, Bioinformatics, 37(11), 1610-1612
https://doi.org/10.1093/bioinformatics/btaa903
RNAseq:

Hafez AI, Soriano B, Elsayed AA, Futami R, Ceprian R, Ramos-Ruiz R, Martinez G, Roig FJ, Torres-Font MA, Naya-Catala F, Calduch-Giner JA, Trilla-Fuertes L, Gamez-Pozo A, Arnau V, Sempere-Luna JM, Perez-Sanchez J, Gabaldon T, Llorens C. 2023.
Client Applications and Server-Side Docker for Management of RNASeq and/or VariantSeq Workflows and Pipelines of the GPRO Suite. Genes; 14(2):267.
https://doi.org/10.3390/genes14020267
We are preparing new publications for STATools, Worksheet and DeNovoSeq, but, meanwhile, you can use this reference:

Futami R, Muñoz-Pomer A, Viu JM, Domínguez-Escribà L, Covelli L, Bernet GP, Sempere JM, Moya A, Llorens C.
GPRO: the professional tool for management, functional analysis and annotation of omic sequences and databases (2011).
Biotechvana Bioinformatics: 2011-SOFT3.



GPRO licensing and Usage           Former versions           TSI-100903-2019-11

Biotechvana


Valencia Lab
Parc Cientific Universitat de Valencia
Carrer del Catedràtic Agustín Escardino, 9. 46980 Paterna (Valencia) Spain
Madrid Lab
Parque Científico de Madrid
Campus de Cantoblanco
Calle Faraday 7, 28049 Madrid Spain
Contact us
Phone: +34 960 06 74 93
Email: biotechvana@biotechvana.com

Supported by


Hipra Scientific S.L.U, Polypeptide Therapeutic Solutions S.L., Biotechvana S.L. and Nostrum Biodiscovery constitute the consortium of enterprises participating in the project "Research of a new vaccine for a human respiratory disease", granted by the CDTI (Center for Industrial Technological Development), and supported by the Ministry of Science and Innovation and financed by the European Union – NextGenerationEU. The main objective of this project is to design a safe immunogenic and effective vaccine against the respiratory syncytial virus.

Biotechvana © 2015
Privacy policy
Política de privacidad
This website use cookies, by continuing to browse the site you are agreeing to our use of cookies. More info about our cookies here.